Matthieu Corvaisier

Colon Cancer Cells Escape 5FU Chemotherapy-Induced Cell Death by Entering Stemness and Quiescence Associated with the c-Yes/YAP Axis

Yasmine Touil, Wassila Igoudjil, Matthieu Corvaisier et al. · Clinical Cancer Research · 2013 · 341 citations

Medicine, Cell Biology, Oncology +17

Molecular Features of the YAP Inhibitor Verteporfin: Synthesis of Hexasubstituted Dipyrrins as Potential Inhibitors of YAP/TAZ, the Downstream Effectors of the Hippo Pathway

Floriane Gibault, Fabrice Bailly, Matthieu Corvaisier et al. · ChemMedChem · 2017 · 80 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +7

Gemcitabine‐induced epithelial‐mesenchymal transition‐like changes sustain chemoresistance of pancreatic cancer cells of mesenchymal‐like phenotype

Mehdi El Amrani, François Corfiotti, Matthieu Corvaisier et al. · Molecular Carcinogenesis · 2019 · 59 citations

Medicine, Cell Biology, Oncology +17

Regulation of cellular quiescence by YAP/TAZ and Cyclin E1 in colon cancer cells: Implication in chemoresistance and cancer relapse

Matthieu Corvaisier, Marjolaine Bauzone, François Corfiotti et al. · Oncotarget · 2016 · 43 citations · Full text

Medicine, Cell Biology, Oncology +17

Toward the Discovery of a Novel Class of YAP–TEAD Interaction Inhibitors by Virtual Screening Approach Targeting YAP–TEAD Protein–Protein Interface

Floriane Gibault, Mathilde Coevoet, Manon Sturbaut et al. · Cancers · 2018 · 43 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17